In Neu transgenic mice, Neu-induced mammary cancer was initiated by two subpopulations of stem-cell-like mammary epithelial cells, identified as such by surface markers of basal cells or luminal progenitor cells (i.e., CD24medCD49fhigh or CD24highCD49flowCD61+, respectively) [38]. The gene discussed is ERBB2; the disease is breast cancer.